While it makes sense for value assessment to be woven into healthcare decision making, relying on a single method to measure value and using this metric to restrict treatment access is shortsighted. IVI’s Jennifer Bright and Mark Linthicum address this concern in a recent article for the American Journal of Managed Care (AJMC).

Read the full article here.